𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Long-Term Efficacy of Rasagiline in Early Parkinson's Disease

✍ Scribed by Lew, Mark F.; Hauser, Robert A.; Hurtig, Howard I.; Ondo, William G.; Wojcieszek, Joanne; Goren, Tamar; Fitzer-Attas, Cheryl J.


Book ID
125547854
Publisher
Informa plc
Year
2010
Tongue
English
Weight
267 KB
Volume
120
Category
Article
ISSN
0020-7454

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Long-term outcome of early versus delaye
✍ Robert A. Hauser; Mark F. Lew; Howard I. Hurtig; William G. Ondo; Joanne Wojcies πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 329 KB πŸ‘ 1 views

## Abstract The purpose of this study to compare the long‐term clinical outcome of early versus delayed rasagiline treatment in early Parkinson's disease (PD). Subjects (N = 404) were randomly assigned to initial treatment with rasagiline (early‐start group) or placebo for 6 months followed by rasa

Long-term antidyskinetic efficacy of ama
✍ Elisabeth Wolf; Klaus Seppi; Regina Katzenschlager; Guenter Hochschorner; Gerhar πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 116 KB πŸ‘ 1 views

## Abstract Several randomized placebo‐controlled trials have consistently shown antidyskinetic effects of amantadine in levodopa treated patients with advanced Parkinson's disease (PD). However, all of these were of short duration and there have been claims that the effect of amantadine on levodop